Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Ilse Hoffman"'
Autor:
Inge Stappaerts, Ilse Hoffman, Vicky Nowé, Denise van der Graaff, Inge Hantson, Sofie Stappers, Liesbeth Vervliet, Walter Moorkens
Publikováno v:
Acta Clinica Belgica. 77:616-623
BackgroundSystemic lupus erythematosus (SLE) is a rheumatological disorder with a heterogeneous clinical presentation and disease course. Case presentationWe report a case concerning a young woman with pleuropneumonia, non-responsive to conventional
Autor:
Jacques Pirenne, Ilse Hoffman, Tim Vanuytsel, Ina Jochmans, Guido Peers, Diethard Monbaliu, Martin Hiele, Marleen Pijpops, Gert De Hertogh, Lutgart De Pourcq, Emilio Canovai, Laurens J. Ceulemans
Publikováno v:
Transplantation. 105:897-904
BACKGROUND: Intestinal transplantation (ITx) is the most expensive abdominal organ transplant. Detailed studies about exact costs and cost-effectiveness compared to home parenteral nutrition (HPN) therapy in chronic intestinal failure are lacking. Th
Autor:
Valérie Badot, K De Knop, C. Langenaken, D. De Cock, Ilse Hoffman, S. Pazmino, M Walschot, L. Corluy, Patrick Verschueren, J. Lenaerts, D. Bertrand, JL Lenaerts, Rene Westhovens, M. Doumen, E. Geens, Veerle Stouten, V. Taelman, Johan Joly, I de Wergifosse, J Mannaerts
Publikováno v:
Scandinavian journal of rheumatology
Objective: In patients with rheumatoid arthritis (RA) in sustained remission, tapering of biological disease-modifying anti-rheumatic drugs can be considered. Tapering has already been investigated, but its feasibility remains to be determined. There
Autor:
Gert Van Assche, Ilse Hoffman, Rafael Torrejon Torres, Raf Bisschops, Rhodri Saunders, Christophe Dooms, Schalk Van der Merwe, Rachel Weissbrod, Ingrid Demedts
OBJECTIVE: Respiratory compromise is a major cause of adverse events during procedural sedation; continuous monitoring is vital for identifying and halting decompensation. We performed a quality improvement investigation to assess patient safety duri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0242bded4867d3443ec378cb191db56
https://lirias.kuleuven.be/handle/123456789/674548
https://lirias.kuleuven.be/handle/123456789/674548
Autor:
Liselot De Vlieger, Lieselot Smolders, Lisa Nuyttens, Sophie Verelst, Christine Breynaert, Tim Vanuytsel, Ilse Hoffman, Dominique MA Bullens
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
Pediatric eosinophilic esophagitis (ped-EoE) is an immune-mediated pathology affecting 34 per 100.000 children. It is characterized by an esophageal inflammation caused by an immune response towards food antigens that come into contact with the esoph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00fb7fc9dfd2fbab6554c854ad27f1c9
https://lirias.kuleuven.be/handle/123456789/676645
https://lirias.kuleuven.be/handle/123456789/676645
Autor:
Gert Van Assche, Ilse Hoffman, Ann Gils, Marc Ferrante, Severine Vermeire, Erwin Dreesen, Karen van Hoeve
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 68:847-853
Therapeutic drug monitoring has been proposed as a useful tool in the management of infliximab (IFX) treated patients with inflammatory bowel disease. The aim of this retrospective study was to determine whether IFX trough levels after induction ther
Autor:
Severine Vermeire, Ann Gils, Gert Van Assche, Erwin Dreesen, Ilse Hoffman, Marc Ferrante, Karen van Hoeve
Publikováno v:
Journal of Crohn's and Colitis. 12:1316-1325
Background The role of therapeutic drug monitoring for infliximab [IFX] therapy in children with inflammatory bowel disease [IBD] is poorly investigated. We determined if IFX exposure correlates with long-term remission in children. Methods In this r
Autor:
Ilse Hoffman, Bart Keymeulen, Peter Bossuyt, Marc Ferrante, Robert Hilbrands, Severine Vermeire, Bram Verstockt, Arnaud Colard, Lucas Wauters, Danny De Looze, Marc Simoens, Isabelle Paquot, Constance Carels, Alexander Goegebuer, Bruno Hauser, An Outtier, Annelies Verreth, Gigi Veereman, Filip Baert, Isabelle Ruytjens, Clara Thienpont
Publikováno v:
Frontiers in Pediatrics, Vol 9 (2021)
Frontiers in Pediatrics
Frontiers in Pediatrics
Background and Aims: The management of chronic inflammatory bowel diseases in youth is challenging. We aimed to determine health literacy (HL), quality of life (QoL) and clinical outcomes in young adults from the BELgian CROhn's disease registry (BEL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::778f56fb3ce2cb22141efe2947f20f8a
https://lirias.kuleuven.be/handle/123456789/672713
https://lirias.kuleuven.be/handle/123456789/672713
Autor:
Ann Gils, Karen van Hoeve, Erwin Dreesen, Marc Ferrante, Ilse Hoffman, Severine Vermeire, Nasim Sadat Seyed Tabib, Sophie Tops
Publikováno v:
The Journal of Pediatrics. 240:150-157.e4
OBJECTIVES: To study infliximab (IFX) pharmacokinetics in children with inflammatory bowel disease (IBD) during induction therapy to predict outcome and explore if other covariates influenced outcome. STUDY DESIGN: All children with IBD starting IFX
Autor:
Marc Ferrante, Paul Declerck, Wannee Kantasiripitak, Debby Thomas, Ilse Hoffman, Severine Vermeire, K van Hoeve, João Sabino, Erwin Dreesen
Publikováno v:
Journal of Crohn's and Colitis. 15:S332-S333
Background Adequate infliximab (IFX) trough concentrations (TCs) during induction treatment are predictive for long-term clinical and endoscopic remission in paediatric patients with inflammatory bowel diseases (IBD). However, under the approved weig